iSpecimen (ISPC) Net Cash Flow (2020 - 2026)

iSpecimen's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 270.66% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at $2.0 million (up 255.89% YoY), while the FY2025 annual figure was $5.0 million, up 1175.19% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$4.1 million, down from $4.1 million in the prior quarter.
• The five-year high for Net Cash Flow was $4.1 million in Q4 2025, with the low at -$11.5 million in Q1 2023.
• The 5-year median for Net Cash Flow is -$399389.0 (2024), against an average of -$1.5 million.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow plunged 604.11% in 2023, then jumped 3138.2% in 2025.
• iSpecimen's Net Cash Flow stood at -$5.3 million in 2022, then jumped by 92.94% to -$377902.0 in 2023, then jumped by 133.49% to $126554.0 in 2024, then surged by 3138.2% to $4.1 million in 2025, then tumbled by 199.12% to -$4.1 million in 2026.
• Business Quant data shows ISPC's Net Cash Flow at -$4.1 million in Q1 2026, $4.1 million in Q4 2025, and $2.2 million in Q3 2025.